Natera, Inc. (NTRA) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript

Natera, Inc. (NTRA) presented at the 8th Annual Wolfe Research Healthcare Conference, updating investors on the company's progress in non-invasive prenatal testing (NIPT) and cancer diagnostics.

The presentation highlighted Natera's growth in the NIPT market, with over 15 million babies tested worldwide, and its expanding presence in cancer diagnostics, with products like Signatera and Prospera.